Binimetinib Intermediate 6

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Binimetinib Intermediate 6 is an important chemical precursor in the synthesis of binimetinib, a MEK inhibitor used in cancer treatment. It finds application primarily in pharmaceutical synthesis, where it serves as a key building block for producing binimetinib, which is employed in therapies for melanoma and other cancers. Additionally, it is used in medicinal chemistry research to support the development and optimization of MEK inhibitor compounds.

Head Office Address

Our Office Addresses